Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...

Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

District Immunization Officer Dr. Ravi Kumar Naik emphasized that complete immunization for every child in Nagarkurnool ...